Microfluidics as an Enabling Technology for Personalized Cancer Therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Microfluidics

Background:

• Personalized cancer treatments require advanced, affordable diagnostic tools.
• Microfluidics technology offers potential solutions for processing limited patient samples and enabling complex cancer models.
• Current microfluidic applications are emerging in genetics, circulating tumor cell monitoring, biomarker analysis, drug sensitivity testing, and disease modeling.

Purpose of the Study:

• To review current microfluidic solutions for personalized cancer diagnostics and treatment.
• To explore the integration and further development of microfluidic technologies in oncology.
• To critically assess the translational steps needed for clinical adoption of microfluidics.

Main Methods:

• Review of existing literature on microfluidic applications in cancer research and diagnostics.
• Analysis of microfluidic systems for genetic analysis, circulating tumor cell (CTC) monitoring, biomarker detection, and phenotypic drug sensitivity testing.
• Discussion of microfluidic platforms for controlled cancer disease modeling.

Main Results:

• Microfluidics enables high-throughput analysis of small-volume samples like patient biopsies.
• Cost-effective and automated microfluidic systems facilitate complex cancer studies and diagnostics.
• Diverse microfluidic approaches show promise in various aspects of cancer care, from genetics to drug response.

Conclusions:

• Microfluidics presents a powerful platform for advancing personalized cancer diagnostics and therapeutics.
• Further development and integration of microfluidic solutions are crucial for clinical translation.
• Bridging the gap between research achievements and routine clinical application requires addressing specific translational challenges.